These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 33681651

  • 1. Perampanel in real-world clinical care of patients with epilepsy: Interim analysis of a phase IV study.
    Wheless J, Wechsler RT, Lancman M, Aboumatar S, Patten A, Malhotra M.
    Epilepsia Open; 2021 Mar; 6(1):79-89. PubMed ID: 33681651
    [Abstract] [Full Text] [Related]

  • 2. PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.
    Wechsler RT, Wheless J, Zafar M, Huesmann GR, Lancman M, Segal E, Chez M, Aboumatar S, Patten A, Salah A, Malhotra M.
    Epilepsia Open; 2022 Jun; 7(2):293-305. PubMed ID: 34942053
    [Abstract] [Full Text] [Related]

  • 3. Perampanel in real-world clinical care of adolescent and adult patients with epilepsy: Results from the retrospective Phase IV PROVE Study.
    Segal E, Wheless J, Moretz K, Penovich P, Patten A, Malhotra M.
    Seizure; 2022 May; 98():87-94. PubMed ID: 35453064
    [Abstract] [Full Text] [Related]

  • 4. PERPRISE: A prospective non-interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic-clonic seizures: First interim analysis.
    Steinhoff BJ, Goldmann T, Kockelmann E, Winter Y, PERPRISE Study Group.
    Epilepsia Open; 2024 Jun; 9(3):926-939. PubMed ID: 38017663
    [Abstract] [Full Text] [Related]

  • 5. Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy.
    Moretz K, Wheless J, Santos C, Segal E, Lancman M, Patten A, Malhotra M.
    Eur J Paediatr Neurol; 2024 May; 50():23-30. PubMed ID: 38569352
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, safety, and tolerability of perampanel in Asian and non-Asian patients with epilepsy.
    Tsai JJ, Ikeda A, Hong SB, Likasitwattanakul S, Dash A.
    Epilepsia; 2019 Mar; 60 Suppl 1():37-46. PubMed ID: 30869165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies.
    Piña-Garza JE, Rosenfeld W, Saeki K, Villanueva V, Yoshinaga H, Patten A, Williams B, Malhotra M.
    Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
    Rektor I, Krauss GL, Inoue Y, Kaneko S, Williams B, Patten A, Malhotra M, Laurenza A, Wechsler RT.
    Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
    [Abstract] [Full Text] [Related]

  • 12. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
    French JA, Krauss GL, Wechsler RT, Wang XF, DiVentura B, Brandt C, Trinka E, O'Brien TJ, Laurenza A, Patten A, Bibbiani F.
    Neurology; 2015 Sep 15; 85(11):950-7. PubMed ID: 26296511
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies.
    Weiping L, Dong Z, Zhen H, Patten A, Dash A, Malhotra M.
    CNS Neurosci Ther; 2021 Mar 15; 27(3):330-340. PubMed ID: 33340263
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Study 508.
    Ravat S, Rohatgi A, Kulkarni R, Jabeen SA, Patil B, Dash A, Malhotra M.
    Epilepsia Open; 2024 Jun 15; 9(3):940-950. PubMed ID: 38124551
    [Abstract] [Full Text] [Related]

  • 15. PROVE-Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Interim Analysis in Pediatric Patients.
    Segal E, Moretz K, Wheless J, Penovich P, Lancman M, Patten A, Malhotra M.
    J Child Neurol; 2022 Mar 15; 37(4):256-267. PubMed ID: 34994582
    [Abstract] [Full Text] [Related]

  • 16. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.
    Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Clément JF, Wang X, Bagul M, Gee M, Zhu J, Squillacote D.
    Epilepsia; 2014 Jul 15; 55(7):1058-68. PubMed ID: 24867391
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures.
    Piña-Garza JE, Lagae L, Villanueva V, Renfroe JB, Laurenza A, Williams B, Kumar D, Meador KJ.
    Epilepsy Behav; 2018 Jun 15; 83():50-58. PubMed ID: 29653338
    [Abstract] [Full Text] [Related]

  • 18. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
    Villanueva V, Montoya J, Castillo A, Mauri-Llerda JÁ, Giner P, López-González FJ, Piera A, Villanueva-Hernández P, Bertol V, Garcia-Escrivá A, Garcia-Peñas JJ, Garamendi I, Esteve-Belloch P, Baiges-Octavio JJ, Miró J, Falip M, Garcés M, Gómez A, Gil-López FJ, Carreño M, Rodriguez-Uranga JJ, Campos D, Bonet M, Querol R, Molins A, Tortosa D, Salas-Puig J.
    Epilepsia; 2018 Sep 15; 59(9):1740-1752. PubMed ID: 30062784
    [Abstract] [Full Text] [Related]

  • 19. A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy.
    Maguire M, Ben-Menachem E, Patten A, Malhotra M, Ngo LY.
    Epilepsy Behav; 2022 Jan 15; 126():108483. PubMed ID: 34953337
    [Abstract] [Full Text] [Related]

  • 20. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
    Alonso-Singer P, Aguilar-Amat Prior MJ, Oliva-Navarro J, Massot-Tarrús A, Giráldez BG, Bermejo P, DeToledo-Heras M, Aledo-Serrano Á, Martínez-Cayuelas E, Tirado-Requero P, Velázquez-Fragua R, López-Sobrino G, Ojeda J.
    Epilepsy Behav; 2022 Sep 15; 134():108836. PubMed ID: 35870432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.